Eastman Kodak CEO James Continenza on shift to drug production

Eastman Kodak made waves on Tuesday with news it is shifting into production of pharmaceutical ingredients with a $765 million government loan under the Defense Production Act. James Continenza, CEO and executive chairman of Eastman Kodak, joins "Squawk Box" to discuss the deal.